Spinal cord compression is characterised by a combination of a progressive history of neurological deficit and a sensory level on examination.
This is a lesion that causes lower motor neurone signs at the level of the lesion and upper motor neurone lesions below that level.
It is a neurological emergency because:
- the final events are ischaemic, so they are fast and irreversible
- the patient may be left in a wheelchair, incontinent of urine
Pain characteristics suggesting spinal metastases:
- severe unremitting back pain
- progressive back pain
- mechanical pain (aggravated by standing, sitting or moving)
- back pain aggravated by straining (for example, coughing, sneezing or bowel movements)
- night-time back pain disturbing sleep
- localised tenderness
- claudication (muscle pain or cramping in the legs when walking or exercising)
Symptoms and signs suggesting cord compression:
- bladder or bowel dysfunction
- gait disturbance or difficulty walking
- limb weakness
- neurological signs of spinal cord or cauda equina compression
- numbness, paraesthesia or sensory loss
- radicular pain
Note that the commonest cause of acute cord compression is metastatic disease.
- metastases to the spinal column are diagnosed in around 16% of all people with cancer and may cause pain, vertebral collapse and spinal cord or root compression
- metastatic spinal cord compression (MSCC) develops in 40% of patients with pre-existing non-spinal bone metastasis
- treatments for patients with MSCC differ based on their life expectancies
- Decompressive surgery is considered to be the “gold standard” in tumours that are not specifically radiosensitive
- To improve the quality of life, patients with a life expectancy of more than 3–6 months may undergo surgery
- Evidence shows that survival of MSCC patients can be improved with palliative decompression before motor deficits occur.
- After motor deficit onset, survival can still be improved with surgery within 7 days.
- Overall survival is better in patients aged <=55 years
- Decompressive surgery is considered to be the “gold standard” in tumours that are not specifically radiosensitive